Thousands of refugees are at risk of being left homeless by the termination of an EU-funded program providing cash assistance and temporary shelter to people granted asylum in Greece.
Appeals from aid groups have mounted, which fear that more than 2,000 men, women and children will face destitution if action is not taken.
“It’s extremely concerning that recognized refugees in Greece are being turned on to the streets amidst a global pandemic,” International Rescue Committee director of policy and advocacy in Europe Imogen Sudbery said. “Without necessary documentation, access to information, language skills or other essential means of becoming self-reliant they are at grave risk of becoming homeless and unemployed.”
Deprived of any safety net, families forced to leave organized accommodation have resorted in recent weeks to sleeping rough in parks and public squares.
Working contracts for hotels hosting recognized refugees under the EU-funded Filoxenia program first ended in December last year, with other hotels following suit in January and last month.
About 750 men, women and children are due to exit the temporary shelters in the coming days as the scheme finally wraps up, the committee said.
“What we’re seeing reflects the wholesale lack of national integration policy that, incredibly, is still a problem so many years after this crisis began,” said Lefteris Papagiannakis, who focuses on refugee issues at non-governmental organization Solidarity Now. “They’re images we’ve seen before, and will see again, unless real efforts are made to include these people in our society.”
Integration of the estimated 80,000 refugees in Greece is now regarded as the single biggest challenge for a country long on the frontline of migrant flows from Asia, Africa and the Middle East.
Since assuming power in July 2019, the Greek government has focused on accelerating asylum claims and relieving overcrowded camps on frontline Aegean islands by transferring successful asylum applicants to the mainland.
Under a law passed aimed at freeing up space in island reception centres, recognized refugees have only a month to make the transition from organized accommodation to being self-sufficient in non-assisted living facilities.
The UN High Commissioner for Refugees has expressed repeated concerns over assistance ending prematurely.
Access to employment and social welfare schemes is often blighted by the hurdles faced in securing things as simple as a tax number or bank account — obstacles heightened by the COVID-19 pandemic.
In theory, recognized refugees can travel to other parts of Europe, but under EU law, they can remain in another member state for only three months before running the risk of being sent back to Greece.
Greek Prime Minister Kyriakos Mitsotakis’ administration said that it would unveil a national integration strategy imminently.
Asked to comment on the risks posed by the closure of hotels for the refugees, Greek Ministry of Migration senior official Manos Logothetis said that Athens was acting according to plan.
“The Filoxenia program was always going to be phased out,” he said. “We have been given the thumbs up and congratulated by the EU for not only doing it, but doing it on time.”
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very